Adverse Effect

Embed Size (px)

Citation preview

  • 7/31/2019 Adverse Effect

    1/11

    Adverse Effect:ethambutol has its pharmacokinetic parameters altered by aluminium hydroxide

    Severity Level:Moderate - These medications may interact resulting in the potential deterioration of the patient's condition. The patient should be monitored forthe possible manifestations of the interaction. Medical intervention or a change in therapy may be required.

    Documentation Level:Good - Although controlled studies may not have been performed, several case reports have been documented and other data strongly su ggeststhis interaction exists.

    ethambutol belongs to the class of EthambutolAntitubercular antibiotic.

    aluminium hydroxide belongs to the class of Aluminium hydroxide

    Aluminium hydroxide is used as an antacid and phosphate-binder.

    Probable Mechanism:Aluminium hydroxide gel reduced and delayed ethambutol serum levels in a study involving 13 tuberculous patients. Aluminium/magnesiumhydroxide coadministration resulted in a reduction in the extent of ethambutol absorption and peak serum levels, in a study involving 14 healthysubjects. The clinical significance of these interactions is undetermined. Administer oral ethambutol and aluminium hydroxide four hours apart tominimise potential interactions.

    Actions to be Taken:1. Administer drugs separately.2. Use combination with caution.

    ceftriaxone

    acenocoumarol

    4-Moderate

    2-Limited

    ceftriaxone causesadditive toxicitywithacenocoumarol

    http://www.mims.com/Indonesia/Viewer/Html/DrugAlertSig.htmhttp://www.mims.com/Indonesia/Viewer/Html/DrugAlertSig.htmhttp://www.mims.com/Indonesia/Viewer/Html/LikeLiHood.htmhttp://www.mims.com/Indonesia/Viewer/Html/LikeLiHood.htmhttp://www.mims.com/Indonesia/Viewer/Html/LikeLiHood.htmhttp://www.mims.com/Indonesia/Viewer/Html/DrugAlertSig.htm
  • 7/31/2019 Adverse Effect

    2/11

    ceftriaxone alteplase

    4-Moderate

    1-NotEstablished

    ceftriaxone causesadditive toxicity withalteplase

    ceftriaxonerecombinant tissueplasminogenactivator

    4-Moderate

    1-NotEstablished

    ceftriaxone causesadditive toxicity withrecombinant tissueplasminogen activator

    ceftriaxonetissue plasminogenactivator

    4-Moderate

    1-NotEstablished

    ceftriaxone causesadditive toxicity withtissue plasminogenactivator

    ceftriaxone tissue-typeplasminogenactivator

    4-Moderate

    1-NotEstablished

    ceftriaxone causes

    additive toxicity withtissue-typeplasminogen activator

    ceftriaxonealuminumacetylsalicylate

    3-Minor1-NotEstablished

    ceftriaxone causesadditive toxicity withaluminumacetylsalicylate

    ceftriaxone aluminiumacetylsalicylate 3-Minor 1-NotEstablished

    ceftriaxone causes

    additive toxicity withaluminiumacetylsalicylate

    ceftriaxone aluminium aspirin 3-Minor1-NotEstablished

    ceftriaxone causesadditive toxicity withaluminium aspirin

    ceftriaxone aluminum aspirin 3-Minor1-NotEstablished

    ceftriaxone causesadditive toxicity with

  • 7/31/2019 Adverse Effect

    3/11

    aluminum aspirin

    ceftriaxone aminosalicylic acid 3-Minor1-NotEstablished

    ceftriaxone causesadditive toxicity with

    aminosalicylic acid

    ceftriaxone4-aminosalicylicacid

    3-Minor1-NotEstablished

    ceftriaxone causesadditive toxicity with 4-aminosalicylic acid

    ceftriaxonecalcium para-aminosalicylate

    3-Minor1-NotEstablished

    ceftriaxone causesadditive toxicity withcalcium para-aminosalicylate

    ceftriaxonepara-aminosalicylicacid

    3-Minor1-NotEstablished

    ceftriaxone causesadditive toxicity withpara-aminosalicylicacid

    ceftriaxone pas 3-Minor1-NotEstablished

    ceftriaxone causesadditive toxicity withpas

    ceftriaxonesodium

    aminosalicylate

    3-Minor1-Not

    Established

    ceftriaxone causesadditive toxicity with

    sodium aminosalicylate

    ceftriaxonesodium p-aminosalicylate

    3-Minor1-NotEstablished

    ceftriaxone causesadditive toxicity withsodium p-aminosalicylate

    ceftriaxone anistreplase4-Moderat

    1-NotEstablished

    ceftriaxone causesadditive toxicity with

  • 7/31/2019 Adverse Effect

    4/11

    e anistreplase

    ceftriaxone aspirin 3-Minor1-NotEstablished

    ceftriaxone causesadditive toxicity with

    aspirin

    ceftriaxone acetylsal acid 3-Minor1-NotEstablished

    ceftriaxone causesadditive toxicity withacetylsal acid

    ceftriaxone acetylsalicylic acid 3-Minor1-NotEstablished

    ceftriaxone causesadditive toxicity withacetylsalicylic acid

    ceftriaxonesalicylic acid

    acetate3-Minor

    1-Not

    Established

    ceftriaxone causesadditive toxicity withsalicylic acid acetate

    ceftriaxone benorilate 3-Minor1-NotEstablished

    ceftriaxone causesadditive toxicity withbenorilate

    ceftriaxone benorylate 3-Minor1-NotEstablished

    ceftriaxone causesadditive toxicity withbenorylate

    ceftriaxone bismuth salicylate 3-Minor 1-NotEstablished

    ceftriaxone causesadditive toxicity withbismuth salicylate

    ceftriaxonebismuthoxysalicylate

    3-Minor1-NotEstablished

    ceftriaxone causesadditive toxicity withbismuth oxysalicylate

    ceftriaxonebismuthsubsalicylate

    3-Minor1-NotEstablished

    ceftriaxone causesadditive toxicity with

  • 7/31/2019 Adverse Effect

    5/11

    bismuth subsalicylate

    ceftriaxonecarbasalatecalcium

    3-Minor1-NotEstablished

    ceftriaxone causesadditive toxicity with

    carbasalate calcium

    ceftriaxonecholine magnesiumtrisalicylate

    3-Minor1-NotEstablished

    ceftriaxone causesadditive toxicity withcholine magnesiumtrisalicylate

    ceftriaxone choline salicylate 3-Minor1-NotEstablished

    ceftriaxone causesadditive toxicity withcholine salicylate

    ceftriaxone ciclosporin4-Moderate

    2-Limited

    ceftriaxone mayincrease the serumconcentration ofciclosporin

    ceftriaxone cyclosporin4-Moderate

    2-Limited

    ceftriaxone mayincrease the serumconcentration ofcyclosporin

    ceftriaxone cyclosporin A4-Moderate

    2-Limited

    ceftriaxone may

    increase the serumconcentration ofcyclosporin A

    ceftriaxone cyclosporine4-Moderate

    2-Limited

    ceftriaxone mayincrease the serumconcentration ofcyclosporine

  • 7/31/2019 Adverse Effect

    6/11

    ceftriaxone diflunisal 3-Minor

    1-NotEstablished

    ceftriaxone causesadditive toxicity withdiflunisal

    ceftriaxone diflunisal lysine 3-Minor 1-NotEstablished

    ceftriaxone causesadditive toxicity withdiflunisal lysine

    ceftriaxone etenzamide 3-Minor1-NotEstablished

    ceftriaxone causesadditive toxicity withetenzamide

    ceftriaxone ethenzamide 3-Minor1-NotEstablished

    ceftriaxone causesadditive toxicity withethenzamide

    ceftriaxone ethoxybenzamide 3-Minor1-NotEstablished

    ceftriaxone causesadditive toxicity withethoxybenzamide

    ceftriaxone fluindione4-Moderate

    2-Limitedceftriaxone causesadditive toxicity withfluindione

    ceftriaxone guacetisal 3-Minor1-NotEstablished

    ceftriaxone causesadditive toxicity with

    guacetisal

    ceftriaxone heparin4-Moderate

    1-NotEstablished

    ceftriaxone causesadditive toxicity withheparin

    ceftriaxone calcium heparin4-Moderate

    1-NotEstablished

    ceftriaxone causesadditive toxicity withcalcium heparin

  • 7/31/2019 Adverse Effect

    7/11

    ceftriaxone heparin calcium

    4-Moderate

    1-NotEstablished

    ceftriaxone causesadditive toxicity withheparin calcium

    ceftriaxone heparinmagnesium

    4-Moderate

    1-NotEstablished

    ceftriaxone causesadditive toxicity withheparin magnesium

    ceftriaxone heparin sodium4-Moderate

    1-NotEstablished

    ceftriaxone causesadditive toxicity withheparin sodium

    ceftriaxoneheparin sodium,porcine

    4-Moderat

    e

    1-NotEstablished

    ceftriaxone causesadditive toxicity withheparin sodium,

    porcine

    ceftriaxone heparin, porcine4-Moderate

    1-NotEstablished

    ceftriaxone causesadditive toxicity withheparin, porcine

    ceftriaxone imidazole salicylate 3-Minor1-NotEstablished

    ceftriaxone causesadditive toxicity withimidazole salicylate

    ceftriaxone imidazole-2-hydroxybenzoate

    3-Minor 1-NotEstablished

    ceftriaxone causes

    additive toxicity withimidazole-2-hydroxybenzoate

    ceftriaxone lysine aspirin 3-Minor1-NotEstablished

    ceftriaxone causesadditive toxicity withlysine aspirin

    ceftriaxone acetylsalicylate 3-Minor 1-Not ceftriaxone causes

  • 7/31/2019 Adverse Effect

    8/11

    lysine Established additive toxicity withacetylsalicylate lysine

    ceftriaxone

    lysine

    acetylsalicylate 3-Minor

    1-Not

    Established

    ceftriaxone causes

    additive toxicity withlysine acetylsalicylate

    ceftriaxonemagnesiumsalicylate

    3-Minor1-NotEstablished

    ceftriaxone causesadditive toxicity withmagnesium salicylate

    ceftriaxonemorpholinesalicylate

    3-Minor1-NotEstablished

    ceftriaxone causesadditive toxicity withmorpholine salicylate

    ceftriaxone phenindione4-Moderate

    2-Limitedceftriaxone causesadditive toxicity withphenindione

    ceftriaxone reteplase4-Moderate

    1-NotEstablished

    ceftriaxone causesadditive toxicity withreteplase

    ceftriaxone salicylamide 3-Minor1-NotEstablished

    ceftriaxone causesadditive toxicity withsalicylamide

    ceftriaxone salol 3-Minor1-NotEstablished

    ceftriaxone causesadditive toxicity withsalol

    ceftriaxone phenyl salicylate 3-Minor1-NotEstablished

    ceftriaxone causesadditive toxicity withphenyl salicylate

    ceftriaxone salsalate 3-Minor 1-Not ceftriaxone causes

  • 7/31/2019 Adverse Effect

    9/11

    Established additive toxicity withsalsalate

    ceftriaxone salicyl salicylate 3-Minor

    1-Not

    Established

    ceftriaxone causes

    additive toxicity withsalicyl salicylate

    ceftriaxonesalicylosalicylicacid

    3-Minor1-NotEstablished

    ceftriaxone causesadditive toxicity withsalicylosalicylic acid

    ceftriaxone salysal 3-Minor1-NotEstablished

    ceftriaxone causesadditive toxicity withsalysal

    ceftriaxone sasapyrine 3-Minor 1-NotEstablished

    ceftriaxone causesadditive toxicity withsasapyrine

    ceftriaxone sodium salicylate 3-Minor1-NotEstablished

    ceftriaxone causesadditive toxicity withsodium salicylate

    ceftriaxonesodium 2-hydroxybenzoate

    3-Minor1-NotEstablished

    ceftriaxone causesadditive toxicity withsodium 2-

    hydroxybenzoate

    ceftriaxone streptokinase4-Moderate

    1-NotEstablished

    ceftriaxone causesadditive toxicity withstreptokinase

    ceftriaxone tenecteplase4-Moderate

    1-NotEstablished

    ceftriaxone causesadditive toxicity withtenecteplase

  • 7/31/2019 Adverse Effect

    10/11

    ceftriaxone urokinase

    4-Moderate

    1-NotEstablished

    ceftriaxone causesadditive toxicity withurokinase

    ceftriaxone vaccine, typhoid 4-Moderate

    1-NotEstablished

    ceftriaxone reduceseffect of vaccine,typhoid

    ceftriaxoneattenuatedsalmonella typhistrain Ty21a

    4-Moderate

    1-NotEstablished

    ceftriaxone reduceseffect of attenuatedsalmonella typhi strainTy21a

    ceftriaxone

    purified Vi capsular

    polysaccharide ofsalmonella typhi

    4-

    Moderate

    1-NotEstablished

    ceftriaxone reduceseffect of purified Vi

    capsularpolysaccharide ofsalmonella typhi

    ceftriaxonesalmonella typhi1000 million

    4-Moderate

    1-NotEstablished

    ceftriaxone reduceseffect of salmonellatyphi 1000 million

    ceftriaxoneSalmonella typhiTy-21a, live

    attenuated

    4-Moderat

    e

    1-Not

    Established

    ceftriaxone reduceseffect of Salmonella

    typhi Ty-21a, liveattenuated

    ceftriaxoneSalmonella typhivaccine

    4-Moderate

    1-NotEstablished

    ceftriaxone reduceseffect of Salmonellatyphi vaccine

    ceftriaxoneVi capsularpolysaccharide ofSalmonella typhi

    4-Moderate

    1-NotEstablished

    ceftriaxone reduceseffect of Vi capsularpolysaccharide of

  • 7/31/2019 Adverse Effect

    11/11

    Salmonella typhi

    ceftriaxoneVi polysaccharide

    typhoid vaccine

    4-Moderat

    e

    1-Not

    Established

    ceftriaxone reduceseffect of Vi

    polysaccharide typhoidvaccine

    ceftriaxone warfarin4-Moderate

    2-Limitedceftriaxone causesadditive toxicity withwarfarin

    ceftriaxone warfarin potassium4-Moderate

    2-Limitedceftriaxone causesadditive toxicity withwarfarin potassium

    ceftriaxone warfarin sodium4-Moderate

    2-Limitedceftriaxone causesadditive toxicity withwarfarin sodium